10 results
S-1
EX-10.14
RVNC
Revance Therapeutics Inc
31 Dec 13
IPO registration
12:00am
capital raising achievements and a payment to the Company of $4 million to be made upon the achievement of certain regulatory milestones. The Company will maintain its minority ownership interest in Revance.
424B4
RVNC
Revance Therapeutics Inc
6 Feb 14
Prospectus supplement with pricing info
12:00am
31, 2011 valuation was prepared on a minority, non-marketable interest basis. Our aggregate enterprise value was determined using the income approach … valuation. The June 30, 2012 valuation was prepared on a minority, non-marketable interest basis. Our aggregate enterprise value was determined using
S-1
RVNC
Revance Therapeutics Inc
31 Dec 13
IPO registration
12:00am
was prepared on a minority, non-marketable interest basis. Our aggregate enterprise value was determined using the income approach. We applied … . The June 30, 2012 valuation was prepared on a minority, non-marketable interest basis. Our aggregate enterprise value was determined using the income
DRS
RVNC
Revance Therapeutics Inc
19 Apr 13
Draft registration statement
12:00am
by our board of directors with assistance from a third party valuation. The December 31, 2011 valuation was prepared on a minority, non-marketable … 30, 2012 was estimated by our board of directors with assistance from a third party valuation. The June 30, 2012 valuation was prepared on a minority
8-K
EX-4.1
06uc l9b6ssiyt
14 Feb 20
Entry into a Material Definitive Agreement
5:04pm
10-K
zgos2s0 02huixj
28 Mar 14
Annual report
12:00am
- Prev
- 1
- Next